| 000 | 01536 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250518043658.0 | ||
| 264 | 0 | _c20200525 | |
| 008 | 202005s 0 0 eng d | ||
| 022 | _a1744-8352 | ||
| 024 | 7 |
_a10.1080/14737159.2019.1631799 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCarausu, Marcela | |
| 245 | 0 | 0 |
_aESR1 mutations: a new biomarker in breast cancer. _h[electronic resource] |
| 260 |
_bExpert review of molecular diagnostics _c07 2019 |
||
| 300 |
_a599-611 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents, Immunological _xpharmacology |
| 650 | 0 | 4 | _aBiomarkers, Tumor |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdiagnosis |
| 650 | 0 | 4 | _aDNA Mutational Analysis |
| 650 | 0 | 4 | _aDrug Discovery |
| 650 | 0 | 4 | _aDrug Resistance, Neoplasm |
| 650 | 0 | 4 |
_aEstrogen Receptor alpha _xchemistry |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGenetic Testing |
| 650 | 0 | 4 | _aGenetic Variation |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMolecular Targeted Therapy |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aBidard, François-Clément | |
| 700 | 1 | _aCallens, Celine | |
| 700 | 1 | _aMelaabi, Samia | |
| 700 | 1 | _aJeannot, Emmanuelle | |
| 700 | 1 | _aPierga, Jean-Yves | |
| 700 | 1 | _aCabel, Luc | |
| 773 | 0 |
_tExpert review of molecular diagnostics _gvol. 19 _gno. 7 _gp. 599-611 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/14737159.2019.1631799 _zAvailable from publisher's website |
| 999 |
_c29788206 _d29788206 |
||